Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-17-017973
Filing Date
2017-05-12
Accepted
2017-05-12 17:41:08
Documents
1
Period of Report
2017-05-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6057
  Complete submission text file 0001127602-17-017973.txt   7456
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 170 WEST TASMAN DRIVE SAN JOSE CA 95134
Business Address
Kramer Kelly A. (Reporting) CIK: 0001629885 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 17840165